Using Heteroatoms as “Natural Labels” in the Quantitative Analysis of Active Pharmaceutical Ingredients by HPLC-ICP-MS

Importance of the Topic

The accurate quantification of heteroatom-containing pharmaceutical compounds is critical for drug development and quality control. Conventional LC-MS/MS methods offer high selectivity but suffer from variable sensitivity depending on compound structure and matrix effects. ICP-MS with inductively coupled plasma provides structure-independent elemental quantification at trace levels. When coupled with HPLC and MS/MS reaction cell technology, ICP-QQQ enables precise analysis of sulfur, phosphorus, and chlorine in APIs and biomolecules without the need for compound-specific tags.

Objectives and Study Overview

This study aims to evaluate HPLC-ICP-QQQ in MS/MS mass-shift mode for the quantitative analysis of selected active pharmaceutical ingredients (APIs) and a monoclonal antibody (mAb) based on their natural heteroatom content. Five APIs containing S, P, or Cl and one IgG2a antibody were analyzed to demonstrate sensitivity, specificity, and applicability across small and large molecules.

Methodology and Instrumentation

Agilent 1260 Infinity Bio-inert HPLC with quaternary pump and autosampler was interfaced to Agilent 8800 Triple Quadrupole ICP-MS. C18 and SEC columns were used for small molecules and mAb separation, respectively. Heteroatoms were detected via MS/MS mass-shift using O2 cell gas for S and P (forming SO+ and PO+) and H2 cell gas for Cl (forming ClH2+). Internal standards Co and Y were introduced postcolumn for tuning and drift monitoring. Optimized gas flows, RF power, and ion optics settings ensured minimal interference and stable signals.

Main Results and Discussion

Sulfonamide APIs showed an MDL of 23 nM (1.5 ppb S) with clear chromatographic separation. The mAb analysis yielded an MDL of 14 nM (40 ng) based on sulfur content. Zoledronic acid in ZOMETA was quantified with 102% recovery and an MDL of 25 nM (1.5 ppb P). Clonidine hydrochloride in Catapres achieved 96% recovery and an MDL of 146 nM (15 ppb Cl). MS/MS mass-shift mode effectively removed polyatomic interferences, enabling robust quantification across varied matrices.

Benefits and Practical Applications

• Structure-independent elemental response reduces matrix effects
• No need for compound-specific calibration tags when natural heteroatoms are present
• Low detection limits in the nanomolar to picogram range
• Applicability to both small-molecule drugs and large biomolecules
• Rapid method development using existing ICP-QQQ infrastructure

Future Trends and Potential Applications

Integration of metal-tagging strategies for compounds lacking natural heteroatoms could expand the scope of ICP-QQQ bioanalysis. Enhanced cell-gas chemistries and improved ion optics may further lower detection limits. Coupling with immunoaffinity or microfluidic systems can enable targeted assays in complex biological matrices. Adoption in regulated QA/QC workflows and therapeutic monitoring is anticipated.

Conclusion

HPLC-ICP-QQQ in MS/MS mode offers a powerful alternative to molecular MS for quantifying S, P, and Cl in pharmaceuticals and biomolecules. The technique delivers high sensitivity, specificity, and accuracy without extensive derivatization or tagging, making it well-suited for drug development and quality control laboratories.

References

1. Esteban-Fernandez D et al. J. Anal. At. Spectrom. 2007;22:1113
2. Bytzek AK et al. Metallomics 2011;3:1049
3. Esteban-Fernandez D et al. Anal. Bioanal. Chem. 2011;401:657
4. Prange A, Profrock D. J. Anal. At. Spectrom. 2008;23:432
5. Sanz-Medel A. Anal. Bioanal. Chem. 2008;391:885
6. He Q et al. J. Anal. At. Spectrom. 2014
7. Iwahata D et al. J. Anal. Sci. Methods Instrum. 2013;3:80
8. Baranov VI et al. Anal. Chem. 2002;74:1629
9. Sugiyama N, Nakano K. Agilent Technical Note 2014;5991-4585EN
10. Wending D et al. J. Rheumatol. 1993;20(2):259